Your session is about to expire
← Back to Search
XMT-1592 for Non-Small Cell Lung Cancer
Study Summary
This trial is testing a new cancer drug to see if it is safe and effective.
- Non-Small Cell Lung Cancer
- Ovarian Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Could I possibly qualify to participate in this research?
"Eligible participants for this study must have a non-small cell lung carcinoma (nsclc) and be between the ages of 18 and 95. So far, the study has recruited a total of 120 candidates."
Does this experiment include geriatric participants?
"Eligibility criteria for this study include being between 18-95 years old."
Is this research study currently looking for new participants?
"This clinical trial, as indicated on clinicaltrials.gov, is no longer actively recruiting patients. The study was originally posted on May 11th, 2020 but was most recently edited on August 29th, 2020. There are currently 2181 other studies recruiting patients."
In how many distinct hospitals is this research project being conducted currently?
"Enrollment for this study is currently underway at 9 different locations, 8 of which are based in major cities such as San Antonio, Dallas and Detroit. If you are considering enrolling, it might be best to choose the nearest site to you in order to limit travel."
Share this study with friends
Copy Link
Messenger